ArticleJournal of medical virology2020
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.
Article in Journal of medical virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis.BMJ open · 2020Pooled it
- Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.Microbial pathogenesis · 2020Pooled it
- The effect of the COVID-19 pandemic on life expectancy in 27 countries.Scientific reports · 2023Article
- Performance Evaluation of a Rapid Antigen Test (RAT) during Omicron Pandemic Wave in Greece, Conducted by Different Personnel, and Comparison with Performance in Previous Wave (Alpha Variant) Period.Diagnostics (Basel, Switzerland) · 2022Article
- Article
- Loss of life expectancy due to respiratory infectious diseases: findings from the global burden of disease study in 195 countries and territories 1990-2017.Journal of population research (Canberra, A.C.T.) · 2022Article
- Rapid Test Ag 2019-nCoV (PROGNOSIS, BIOTECH, Larissa, Greece); Performance Evaluation in Hospital Setting with Real Time RT-PCR.International journal of environmental research and public health · 2021Article
- SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.Molecular neurobiology · 2021Review
- Article
- COVID-19 and inflammatory bowel disease: A pathophysiological assessment.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021Review
- Variables Affecting Mortality Among COVID-19 Patients With Lung Involvement Admitted to the Emergency Department.Cureus · 2021Article
- Do risk factors at the time of hospital admission differ by sex for in-hospital mortality from coronavirus disease 2019 (COVID-19)?Antimicrobial stewardship & healthcare epidemiology : ASHE · 2021Article
- Transcription and DNA Methylation Patterns of Blood-Derived CD8Gastroenterology · 2021Article
- Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?Neuroendocrinology · 2021Review
- COVID-19: Molecular and Cellular Response.Frontiers in cellular and infection microbiology · 2021Review
- Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.Frontiers in physiology · 2021Review
- Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.Journal of medical virology · 2020Article
- Lymphocyte percentage and hemoglobin as a joint parameter for the prediction of severe and nonsevere COVID-19: a preliminary study.Annals of translational medicine · 2020Article
- Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis.EBioMedicine · 2020Article
- Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.EBioMedicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The outbreak of SARS-CoV-2 has become a pandemic with significant mortality. Published studies described clinical characteristics of the disease contain small cohorts from individual centers or larger series consisting of mixed series from multiple different hospitals. We report here analyses of mortality and disease severity among 402 patients from a single hospital. The cohort includes 297 patients with confirmed and 105 with clinical diagnosis. The latter group consists of cases with inconclusive nucleic acid test but meeting the criteria for clinical diagnosis. Data are compared between sexes and among different age groups. The overall case fatality is 5.2%. However, age at 70 years or older is associated with a significantly higher mortality (17.8%) and higher rate of severe and critical illness (57.5%). Case fatality is 8% in patients 50 years of age or older, and 1.2% in those younger than 50 years. In addition, case fatality is 7.6% in male patients, as opposed to 2.9% in females, demonstrating a clear sex difference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.